Literature DB >> 20685659

Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Anna Tranell1, Eva Maria Fenyö, Stefan Schwartz.   

Abstract

HIV-1 non-coding exon 3 can either be spliced to exons 4, 4a, 4b, 4c, and 5 to generate tat, rev, and nef mRNAs or remain unspliced to produce the 13a7 vpr mRNA. Here we show that serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) inhibit splicing from the 5'-splice site of exon 3 thereby causing an accumulation of the partially unspliced 13a7 vpr mRNA. In contrast, serine- and arginine-rich protein 40 (SRp40) induces splicing from exon 3 to exon 4, thereby promoting the production of the 1347 tat mRNA. We demonstrate that SRp55 stimulates vpr mRNA production by interacting with the previously identified HIV-1 splicing enhancer named GAR and inhibiting its function. This inhibition requires both serine arginine-rich and RNA-binding domains of SRp55, indicating that production of HIV-1 vpr mRNA depends on the interaction of SRp55 with an unknown factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685659      PMCID: PMC2951228          DOI: 10.1074/jbc.M109.077453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

4.  A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.

Authors:  Virginie Marchand; Agnès Méreau; Sandrine Jacquenet; Denise Thomas; Annie Mougin; Renata Gattoni; James Stévenin; Christiane Branlant
Journal:  J Mol Biol       Date:  2002-11-01       Impact factor: 5.469

5.  A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.

Authors:  S Jacquenet; A Méreau; P S Bilodeau; L Damier; C M Stoltzfus; C Branlant
Journal:  J Biol Chem       Date:  2001-08-28       Impact factor: 5.157

6.  RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.

Authors:  P S Bilodeau; J K Domsic; A Mayeda; A R Krainer; C M Stoltzfus
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.

Authors:  S Kammler; C Leurs; M Freund; J Krummheuer; K Seidel; T O Tange; M K Lund; J Kjems; A Scheid; H Schaal
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

8.  Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region.

Authors:  Lisa Wiklund; Marcus Sokolowski; Anette Carlsson; Margaret Rush; Stefan Schwartz
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

9.  Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.

Authors:  Dibyakanti Mandal; Colin M Exline; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

10.  Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.

Authors:  A Staffa; A Cochrane
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more
  12 in total

1.  An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Authors:  Yan Wang; Junning Wang; Lei Gao; Stefan Stamm; Athena Andreadis
Journal:  Gene       Date:  2011-06-30       Impact factor: 3.688

2.  The adipogenic transcriptional cofactor ZNF638 interacts with splicing regulators and influences alternative splicing.

Authors:  Chen Du; Xinran Ma; Sunitha Meruvu; Lynne Hugendubler; Elisabetta Mueller
Journal:  J Lipid Res       Date:  2014-07-14       Impact factor: 5.922

Review 3.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

4.  Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis.

Authors:  Theresa A Gipson; Andreas Neueder; Nancy S Wexler; Gillian P Bates; David Housman
Journal:  RNA Biol       Date:  2013-10-11       Impact factor: 4.652

5.  Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication.

Authors:  Steffen Erkelenz; Frank Hillebrand; Marek Widera; Stephan Theiss; Anaam Fayyaz; Daniel Degrandi; Klaus Pfeffer; Heiner Schaal
Journal:  Retrovirology       Date:  2015-03-28       Impact factor: 4.602

6.  Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.

Authors:  Xiaoze Li; Cecilia Johansson; Jacob Glahder; Ann-Kristin Mossberg; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2013-09-05       Impact factor: 16.971

Review 7.  Can the HIV-1 splicing machinery be targeted for drug discovery?

Authors:  Zodwa Dlamini; Rodney Hull
Journal:  HIV AIDS (Auckl)       Date:  2017-03-10

Review 8.  Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Authors:  Aurélie Delannoy; Mikaël Poirier; Brendan Bell
Journal:  Viruses       Date:  2019-03-18       Impact factor: 5.048

9.  Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.

Authors:  Joonbae Seo; Natalia N Singh; Eric W Ottesen; Senthilkumar Sivanesan; Maria Shishimorova; Ravindra N Singh
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

10.  Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.

Authors:  Wim Trypsteen; Cory H White; Amey Mukim; Celsa A Spina; Ward De Spiegelaere; Steve Lefever; Vicente Planelles; Alberto Bosque; Christopher H Woelk; Linos Vandekerckhove; Nadejda Beliakova-Bethell
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.